Affiliations 

  • 1 Gastro-Obeso-Center Institute of Metabolic Optimization, São Paulo, Brazil. ramos.almino@gmail.com
  • 2 Hopital Européen Georges Pompidou, Paris, France
  • 3 Sunderland Royal Hospital, Sunderland, UK
  • 4 Department of Surgery Alfred Health, Monash University, Melbourne, Australia
  • 5 Adelaide Bariatric Centre, Flinders Private Hospital, Bedford Park, Adelaide, South Australia, Australia
  • 6 Science Right Research Consulting, London, Ontario, Canada
  • 7 Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Obes Surg, 2020 May;30(5):1625-1634.
PMID: 32152841 DOI: 10.1007/s11695-020-04519-y

Abstract

BACKGROUND: One-anastomosis gastric bypass (OAGB-MGB) is currently the third performed primary bariatric surgical procedure worldwide. However, the procedure is hampered by numerous controversies and there is considerable variability in surgical technique, patient selection, and pre- and postoperative care among the surgeons performing this procedure. This paper reports the results of a modified Delphi consensus study organized by the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO).

METHODS: Fifty-two internationally recognized bariatric experts from 28 countries convened for voting on 90 consensus statements over two rounds to identify those on which consensus could be reached. Inter-voter agreement of ≥ 70% was considered consensus, with voting participation ≥ 80% considered a robust vote.

RESULTS: At least 70% consensus was achieved for 65 of the 90 questions (72.2% of the items), 61 during the first round of voting and an additional four in the second round. Where consensus was reached on a binary agree/disagree or yes/no item, there was agreement with the statement presented in 53 of 56 instances (94.6%). Where consensus was reached on a statement where options favorable versus unfavorable to OAGB-MGB were provided, including statements in which OAGB-MGB was compared to another procedure, the response option favorable to OAGB-MGB was selected in 13 of 23 instances (56.5%).

CONCLUSION: Although there is general agreement that the OAGB-MGB is an effective and usually safe option for the management of patients with obesity or severe obesity, numerous areas of non-consensus remain in its use. Further empirical data are needed.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.